Bilobar Colorectal Liver Metastases: Treatment Options

Surgical Oncology Clinics of North America

Volumn 17, Issue 3, 2008, Pages 553-568

  Jaeck, Daniel ^a   Pessaux, Patrick ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT THERAPY; ARTIFICIAL EMBOLISM; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CRYOTHERAPY; ELECTROLYSIS; HUMAN; INTERMETHOD COMPARISON; LASER THERMOTHERAPY; LIVER FUNCTION; LIVER METASTASIS; LIVER PARENCHYMA; LIVER RESECTION; LYMPH NODE METASTASIS; MICROWAVE THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN EMBOLIZATION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PREOPERATIVE CARE; PROGNOSIS;

EID: 43449101533     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.02.006     Document Type: Review

References (85)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Remontet L., Estève J., Bouvier A.M., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 51 (2003) 3-30
3. Fong Y., Kemeny N., Paty P., et al. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 12 (1996) 219-252
4. Steele G.J., and Ravikumar T.S. Resection of hepatic metastases from colorectal carcinoma: biologic perspectives. Ann Surg 210 (1989) 127-138
5. Simmonds P.C., Primrose J.N., Colquitt J.L., et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94 (2006) 982-999
6. Jaeck D., Bachellier P., Guiguet M., et al. Long-term survival following resection of colorectal hepatic metastases: Association Française de Chirurgie. Br J Surg 84 (1997) 977-980
7. Nordlinger B., Guiguet M., Vaillant J.C., et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection based on 1568 patients. Cancer 77 (1996) 1254-1262
8. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-321
9. Hughes K.S., Simons R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 103 (1988) 278-288
10. Doci R., Gennari L., Bignami P., et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78 (1991) 797-801
11. Ercolani G., Grazi G.L., Ravaioli M., et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 137 (2002) 1187-1192
12. Sheu J.C., Sung J.L., Chen D.S., et al. Ultrasonography of small hepatic tumors using high-resolution linear-array real time instruments. Radiology 150 (1984) 797-802
13. Chezmar J.L., Rumancik W.M., Megibow A.J., et al. Liver and abdominal screening in patients with cancer: CT versus MR imaging. Radiology 168 (1988) 43-47
14. Strotzer M., Gmeinwieser J., Schmidt J., et al. Diagnosis of liver metastasis from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plan MR imaging. Acta Radiol 38 (1997) 986-992
15. Kamel I.R., and Bluemke D.A. MR imaging of liver tumors. Radiol Clin North Am 41 (2003) 51-65
16. Scott D.J., Guthrie J.A., Arnold P., et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. Clin Radiol 56 (2001) 235-242
17. Sica G.T., Ji H., and Ross P.R. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 174 (2000) 691-698
18. Bipat S., van Leeuwen M.S., Comans E.F., et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis: meta-analysis. Radiology 237 (2005) 123-131
19. Rappeport E.D., and Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging 32 (2007) 624-634
20. Carnaghi C., Tronconi M.C., Rimassa L., et al. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy. Nucl Med Rev Cent East Eur 10 (2007) 12-15
21. Lubezky N., Metser U., Geva R., et al. The role and limitations of 18-fluoro-2-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11 (2007) 472-478
22. Stone H.H., Long W.B., Smith R.B., et al. Physiological considerations in major hepatic resection. Am J Surg 117 (1969) 78-84
23. Zorzi D., Laurent A., Pawlik T.M., et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94 (2007) 274-286
24. Okamato E., Kyo A., Yamanaka N., et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 95 (1984) 586-592
25. Kubota K., Makuuchi M., Kusaka K., et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26 (1997) 1176-1181
26. Soyer P., Roche A., Elias D., et al. Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. Radiology 184 (1992) 695-697
27. Truant S., Oberlin O., Sergent G., et al. Remnant liver volume to body weight ratio ≥ 0.5%: a new cut-off value to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204 (2007) 22-33
28. Makuuchi M., Thai B.L., Takayasu K., et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107 (1990) 521-527
29. Jaeck D., Oussoultzoglou E., Rosso E., et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240 (2004) 1037-1051
30. Hemming A.W., Scudamore C.H., Shackleton C.R., et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163 (1992) 515-518
31. Makuuchi M., Kosuge T., Takayama T., et al. Surgery for small liver cancers. Semin Surg Oncol 9 (1993) 298-304
32. Ozawa K. Hepatic function and liver resection. J Gastroenterol Hepatol 5 (1990) 296-309
33. Ueda I., Mori K., Sakai Y., et al. Noninvasive evaluation of cytochrome-C-oxidase activity of the liver. Its prognostic value for hepatic resection. Arch Surg 129 (1994) 303-308
34. Lau H., Man K., Fan S.T., et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84 (1997) 1255-1259
35. Jaeck D., and Bachellier P. Quel traitement chirurgical proposer dans les cancers du colon avec métastases viscérales (synchrones et métachrones)? Conférence de consensus. Gastroenterol Clin Biol 22 (1998) S168-S176
36. Jaeck D., Nakano H., Bachellier P., et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 9 (2002) 430-438
37. Jaeck D. Significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 10 (2003) 1007-1011
38. Beckurts K.T., Hölscher A.H., Thorban S., et al. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 84 (1997) 1081-1084
39. Bengtsson G., Carlsson G., Hafström L., et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141 (1981) 586-589
40. Regnard J.F., Grunenwald D., Spaggiari L., et al. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 66 (1998) 214-218
41. Elias D., Benizri E., Pocard M., et al. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32 (2006) 632-636
42. Carmignani C.P., Ortega-Perez G., and Sugarbaker P.H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 30 (2004) 391-398
43. Elias D., Liberale G., Vernerey D., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12 (2005) 900-909
44. Nordlinger B., Sorbye H., Collette L., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371 9617 (2008) 1007-1016
45. Tanaka K., Adam R., Shimada H., et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90 (2003) 963-969
46. Leonard G.D., Brenner B., and Kemeny N.E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23 (2005) 2038-2048
47. Bismuth H., Adam R., Levi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224 (1996) 509-522
48. Miyanari N., Mori T., Takahashi K., et al. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer. Dis Colon Rectum 45 (2002) 1503-1509
49. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
50. Elias D., Lasser P., Rougier P., et al. Frequency, technical aspects, results and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 180 (1995) 213-219
51. Link K.H., Pillasch J., Formentini A., et al. Downstaging by regional chemotherapy of nonresectable isolated colorectal liver metastases. Eur J Surg Oncol 25 (1999) 381-388
52. Meric F., Patt Y.Z., Curley S.A., et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7 (2000) 490-495
53. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
54. Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
55. Niu R., Yan T.D., Zhu J.C., et al. Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma. Ann Surg Oncol 14 (2007) 2078-2087
56. Sotsky T.K., and Ravikumar T.S. Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin Oncol 29 (2002) 183-191
57. Adam R., Akpinar E., Johann M., et al. Place of cryotherapy in the treatment of malignant liver tumors. Ann Surg 225 (1997) 39-50
58. Ruers T.J., Joosten J., Jager G.J., et al. Long-term results of treating hepatic colorectal metastases with cryotherapy. Br J Surg 88 (2001) 844-849
59. Seifert J.K., and Morris D.L. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 228 (1998) 201-208
60. Mulier S., Mulier P., Ni Y., et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 89 (2002) 1206-1222
61. Curley S.A., Izzo F., Delrio P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230 (1999) 1-8
62. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-825
63. Elias D., Baton O., Sideris L., et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 90 (2005) 36-40
64. Ouellet J.F., Pessaux P., Pocard M., et al. Transmetastasis curative liver resection immediately following radiofrequency destruction. J Surg Oncol 81 (2002) 108-110
65. Elias D., Manganas D., Benizri E., et al. The trans-metastasis hepatectomy (through metastases previously ablated with radiofrequency): results of a 13-case study of colorectal cancer. J Surg Oncol 93 (2006) 8-12
66. Shibata T., Niinobu T., Ogata N., et al. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89 (2000) 276-284
67. Tanaka K., Shimada H., Nagano Y., et al. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 139 (2006) 263-273
68. Armstrong J.G., Anderson L.L., Harrison L.B., et al. Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer 73 (1994) 1800-1804
69. Amin Z., Brown S.G., and Lees W.R. Local treatment of colorectal liver metastases. A comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol 48 (1993) 166-171
70. Bleicher R.J., Allegra D.P., Nora D.T., et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 10 (2003) 52-58
71. Finlay I.G., Seifert J.K., Stewart G.J., et al. Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Eur J Surg Oncol 26 (2000) 199-202
72. Bismuth H., Houssin D., and Castaing D. Major and minor segmentectomies "réglées" in liver surgery. World J Surg 6 (1982) 10-24
73. De Baere T., Roche A., Elias D., et al. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24 (1996) 1386-1391
74. Azoulay D., Castaing D., Smail A., et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231 (2000) 480-486
75. Abdalla E.K., Hicks M.E., and Vauthey D.N. Portal vein embolization: rationale, technique and future prospects. Br J Surg 88 (2001) 165-175
76. Rous P., and Larimore L. Relation of the portal blood to liver maintenance. A demonstration of liver atrophy conditional on compensation. J Exp Med 31 (1920) 609-632
77. Nagino M., Nimura Y., Kondo S., et al. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200 (1996) 559-563
78. Tsuge H., Mimura H., Kawata N., et al. Right portal embolization before extended right hepatectomy using laparoscopic catheterization of the ileocolic vein: a prospective study. Surg Laparosc Endosc 4 (1994) 258-263
79. Goere D., Farges O., Leporrier J., et al. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 10 (2006) 365-370
80. Oussoultzoglou E., Bachellier P., Rosso E., et al. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg 244 (2006) 71-79
81. Elias D., De Baere T., Roche A., et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86 (1999) 784-788
82. Adam R., Laurent A., Azoulay D., et al. Two-stage hepatectomy: a planed strategy to treat irresectable liver tumors. Ann Surg 232 (2000) 777-785
83. Shimada H., Tanaka K., Masui H., et al. Results of surgical treatment for multiple (≥ 5 nodules) bilobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg 389 (2004) 114-121
84. Togo S., Nagano Y., Masui H., et al. Two-stage hepatectomy for multiple bilobar liver metastases from colorectal cancer. Hepatogastroenterology 52 (2005) 913-919
85. Adam R., Miller R., Pitombo M., et al. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 16 (2007) 525-536